Clinical Trials Browser

Phase 2/3 × Albumin-Bound Paclitaxel × 90 days × Clear all

NCT06115499 2026-01-07

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Phase 2/3 Active not recruiting

Gastrointestinal

Pancreatic Neoplasms